The tendonitis treatment market size has grown steadily in recent years. It will grow from $221.21 billion in 2024 to $228.79 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to pharmaceutical developments, increased sports injuries, aging population, occupational factors, awareness and education.
The tendonitis treatment market size is expected to see strong growth in the next few years. It will grow to $279.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to government support and funding, personalized medicine, expansion of regenerative therapies, rise in demand for non-invasive treatments, remote monitoring and telehealth. Major trends in the forecast period include research and development, regenerative therapies, advancements in physical therapy, focus on minimally invasive treatments, telemedicine for remote consultations.
The increasing occurrence of sports injuries is anticipated to drive the growth of the tendonitis treatment market in the future. A sports injury refers to any injury or trauma sustained during sports or physical activities, affecting muscles, tendons, ligaments, bones, and joints. Treatment for tendonitis related to sports injuries typically involves a combination of rest, pain management, and physical therapy to promote recovery of the injured tendon, reduce swelling, and support the affected area. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2022, the highest injury rate was found in outdoor team sports, impacting approximately 26% of participants. Combat sports followed closely with a 16% injury rate, while indoor team sports, motor sports, and equestrian sports each had around 15% of participants injured (ASC, 2023). Thus, the rising prevalence of sports injuries is fueling the growth of the tendonitis treatment market.
The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.
Major companies in the tendonitis treatment market are concentrating on developing technologically advanced solutions, such as stem cell therapies, to enhance healing and shorten recovery times for patients. Stem cell therapies utilize stem cells to promote healing and repair damaged tissues in the body. These treatments harness the regenerative capabilities of stem cells to address various conditions, including tendonitis, by improving tissue regeneration and reducing inflammation. For example, in April 2022, C.H. Boehringer Sohn AG & Co. KG, a pharmaceutical company based in Germany, launched RenuTend to improve the healing of tendon and suspensory ligament injuries in horses. RenuTend is a targeted stem cell therapy designed to enhance tendon healing by promoting parallel fiber alignment and minimizing scar tissue formation, which is vital for preventing reinjury in horses. Administered through intralesional injection, this innovative treatment demonstrates proven efficacy and consistent results, representing a significant advancement in equine veterinary medicine.
Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.
In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.
Major companies operating in the tendonitis treatment market include Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Össur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.
North America was the largest region in the tendonitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tendonitis treatment involves methods aimed at reducing inflammation in the tissue that connects muscles and bones, known as tendons. The goal is to apply various therapies that restore strength and flexibility to the affected tendons, alleviating inflammation and pain in the affected area.
The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.
The tendonitis treatment market research report is one of a series of new reports that provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The tendonitis treatment market size is expected to see strong growth in the next few years. It will grow to $279.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to government support and funding, personalized medicine, expansion of regenerative therapies, rise in demand for non-invasive treatments, remote monitoring and telehealth. Major trends in the forecast period include research and development, regenerative therapies, advancements in physical therapy, focus on minimally invasive treatments, telemedicine for remote consultations.
The increasing occurrence of sports injuries is anticipated to drive the growth of the tendonitis treatment market in the future. A sports injury refers to any injury or trauma sustained during sports or physical activities, affecting muscles, tendons, ligaments, bones, and joints. Treatment for tendonitis related to sports injuries typically involves a combination of rest, pain management, and physical therapy to promote recovery of the injured tendon, reduce swelling, and support the affected area. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2022, the highest injury rate was found in outdoor team sports, impacting approximately 26% of participants. Combat sports followed closely with a 16% injury rate, while indoor team sports, motor sports, and equestrian sports each had around 15% of participants injured (ASC, 2023). Thus, the rising prevalence of sports injuries is fueling the growth of the tendonitis treatment market.
The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.
Major companies in the tendonitis treatment market are concentrating on developing technologically advanced solutions, such as stem cell therapies, to enhance healing and shorten recovery times for patients. Stem cell therapies utilize stem cells to promote healing and repair damaged tissues in the body. These treatments harness the regenerative capabilities of stem cells to address various conditions, including tendonitis, by improving tissue regeneration and reducing inflammation. For example, in April 2022, C.H. Boehringer Sohn AG & Co. KG, a pharmaceutical company based in Germany, launched RenuTend to improve the healing of tendon and suspensory ligament injuries in horses. RenuTend is a targeted stem cell therapy designed to enhance tendon healing by promoting parallel fiber alignment and minimizing scar tissue formation, which is vital for preventing reinjury in horses. Administered through intralesional injection, this innovative treatment demonstrates proven efficacy and consistent results, representing a significant advancement in equine veterinary medicine.
Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.
In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.
Major companies operating in the tendonitis treatment market include Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Össur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.
North America was the largest region in the tendonitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tendonitis treatment involves methods aimed at reducing inflammation in the tissue that connects muscles and bones, known as tendons. The goal is to apply various therapies that restore strength and flexibility to the affected tendons, alleviating inflammation and pain in the affected area.
The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.
The tendonitis treatment market research report is one of a series of new reports that provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Tendonitis Treatment Market Characteristics3. Tendonitis Treatment Market Trends and Strategies4. Tendonitis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Tendonitis Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Tendonitis Treatment Market34. Recent Developments in the Tendonitis Treatment Market
5. Global Tendonitis Treatment Growth Analysis and Strategic Analysis Framework
6. Tendonitis Treatment Market Segmentation
7. Tendonitis Treatment Market Regional and Country Analysis
8. Asia-Pacific Tendonitis Treatment Market
9. China Tendonitis Treatment Market
10. India Tendonitis Treatment Market
11. Japan Tendonitis Treatment Market
12. Australia Tendonitis Treatment Market
13. Indonesia Tendonitis Treatment Market
14. South Korea Tendonitis Treatment Market
15. Western Europe Tendonitis Treatment Market
16. UK Tendonitis Treatment Market
17. Germany Tendonitis Treatment Market
18. France Tendonitis Treatment Market
19. Italy Tendonitis Treatment Market
20. Spain Tendonitis Treatment Market
21. Eastern Europe Tendonitis Treatment Market
22. Russia Tendonitis Treatment Market
23. North America Tendonitis Treatment Market
24. USA Tendonitis Treatment Market
25. Canada Tendonitis Treatment Market
26. South America Tendonitis Treatment Market
27. Brazil Tendonitis Treatment Market
28. Middle East Tendonitis Treatment Market
29. Africa Tendonitis Treatment Market
30. Tendonitis Treatment Market Competitive Landscape and Company Profiles
31. Tendonitis Treatment Market Other Major and Innovative Companies
35. Tendonitis Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Tendonitis Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on tendonitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tendonitis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendonitis treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Treatment Type: Therapeutic Treatment; Hot and Cold Therapy; Physical Therapy; Shockwave Therapy; Surgical Treatment2) By Condition Type: Tennis Elbow; Golfer's Elbow; Pitcher's Elbow; Jumper's Knee; Swimmer's Shoulder; Achilles Tendonitis
3) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users
Subsegments:
1) By Therapeutic Treatment: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid Injections; Platelet-Rich Plasma (PRP) Therapy2) By Hot and Cold Therapy: Heat Packs; Ice Packs; Contrast Therapy
3) By Physical Therapy: Stretching Exercises; Strengthening Exercises; Manual Therapy
4) By Shockwave Therapy: Radial Shockwave Therapy; Focused Shockwave Therapy
5) By Surgical Treatment: Tendon Repair Surgery; Tenotomy; Arthroscopy
Key Companies Mentioned: Merck & Co. Inc.; Bayer AG; Boehringer Ingelheim GmbH; Abbott Laboratories; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Merck & Co. Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Abbott Laboratories
- Pfizer Inc.
- Almatica Pharma Inc.
- Teva Pharmaceutical Industries Ltd.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Össur hf
- Tynor India Ltd.
- Arthrex Inc.
- CONMED Corporation
- TendoMed Inc.
- BioPro Inc.
- Aevumed Inc.
- Alafair Biosciences Inc.
- AstraZeneca plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Medtronic plc
- Boston Scientific Corporation
- Wright Medical Group N.V.
- Breg Inc.
- Mueller Sports Medicine Inc.
- Bauerfeind AG
- BSN medical GmbH
- Henry Schein Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 228.79 Billion |
| Forecasted Market Value ( USD | $ 279.17 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
